VBA
GILD icon

von Borstel & Associates’s Gilead Sciences GILD Stock Holding History

von Borstel & Associates’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,955
Closed -$349K – 85
2025
Q3 		$349K Buy
+2,955
New +$336K 0.05% 111
2025
Q2 		– Sell
-150
Closed -$16K – 70
2025
Q1 		$16K Buy
+150
New +$15.5K ﹤0.01% 127

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

von Borstel & Associates's GILD Position: Q4 2025 in Review

von Borstel & Associates sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 2,955 shares — an estimated $349K sold.

von Borstel & Associates first reported a position in GILD in Q1 2025 and held it in 2 quarters. The position peaked at $349K in Q3 2025. 2,228 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • von Borstel & Associates reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • von Borstel & Associates sold 2,955 Gilead Sciences shares in Q4 2025, an estimated $349K.
  • von Borstel & Associates first reported a position in Gilead Sciences in Q1 2025 and held it in 2 quarters.
  • von Borstel & Associates's Gilead Sciences position peaked at $349K in Q3 2025.
  • 2,228 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on von Borstel & Associates's 13F filing for Q4 2025, filed 12 Feb 2026.